Novel Strategies for Diagnosis and Treatment of Heart Failure

Dear Colleagues,

Heart failure (HF) is a complex clinical syndrome that may be caused by a number of structural and/or functional cardiac abnormalities. Developing the condition will result in a reduced cardiac output and/or elevated intracardiac pressures at rest or during stress.

As a growing public health problem with a prevalence of 1–2% in the adult population, HF impacts heavily on patient survival, quality of life and health care costs. Despite the advancement in medical and device therapy, the management of HF remains a challenge.

The early and accurate diagnosis of HF, paired with proper identification of the underlying etiology, is of great importance for treatment and ultimately for enhancing prognosis and quality of life.

In particular, HF is one of the most severe clinical manifestations of classical and novel cancer therapies and can occur either acutely or after years of treatment. As suggested by recent cardio-oncology guidelines, prevention and early detection have become a priority.

Current clinical strategies for the management of patients with HF are heavily based on information provided by multimodality cardiovascular imaging that allows non-invasive morphological and functional assessment, tissue characterization, blood flow and perfusion evaluation.

Therefore, further research on cardiovascular imaging may substantially contribute to the early etiological diagnosis, prognostic stratification and treatment management of HF patients.

In this Special Issue, we invite experts in the field of HF and Cardioncology to submit their original research and/or systematic reviews covering one or more of the following topics:

1. Recent advances in heart failure treatment;
2. Expert reviews on the latest and ongoing RCTs on HF medications;
3. Multimodality imaging as an approach to individualize treatment, guide long-term management, and stratify prognosis in HF;
4. Multimodality imaging for assessment of specific HF etiologies;
5. Multimodality imaging in risk stratification, early detection of cardiovascular sequelae of cancer and related therapies.

Dr. Carla Contaldi
Dr. Giuseppe Pacileo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• heart failure treatment
• HFrEF
• HFpEF
• cardiovascular pharmacotherapy
• multimodality cardiovascular imaging
• echocardiography
• cardiac magnetic resonance
• cardioncology
• cardiotoxicity